Compounds > pentazirinocyclodiphosphathiazene
Page last updated: 2024-08-25

pentazirinocyclodiphosphathiazene and Leukopenia

pentazirinocyclodiphosphathiazene has been researched along with Leukopenia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koops, HS; Mulder, NH; Rodenhuis, S; Sleijfer, DT; van de Grampel, JC1
Carpentier, Y; Cattan, A; Coninx, P; Garbe, E; Jezekova, D; Nasca, S1

Other Studies

2 other study(ies) available for pentazirinocyclodiphosphathiazene and Leukopenia

ArticleYear
Phase I clinical trial of (NPAz2)2NSOAz: 'SOAz'.
    Cancer chemotherapy and pharmacology, 1983, Volume: 10, Issue:3

    Topics: Adult; Aged; Antineoplastic Agents; Azirines; Dose-Response Relationship, Drug; Drug Evaluation; Female; Humans; Leukocyte Count; Leukopenia; Male; Middle Aged; Neoplasms; Platelet Count; Thrombocytopenia

1983
Phase I study of SOAz.
    Cancer treatment reports, 1982, Volume: 66, Issue:12

    Topics: Adult; Aged; Antineoplastic Agents; Azirines; Drug Administration Schedule; Drug Evaluation; Female; Humans; Leukopenia; Male; Middle Aged; Neoplasms; Thrombocytopenia

1982